Cream or pill? new study tests best way to treat fungal skin infection
NCT ID NCT07331792
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two treatments for pityriasis versicolor, a fungal skin infection that causes discolored patches. One group will apply a clotrimazole cream twice daily for two weeks, while the other takes itraconazole pills daily for five days. The trial aims to see which approach works better, involving 86 participants aged 15-50.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
clotrimazole and itraconazole
What this could lead to
If this trial succeeds, it could show which treatment works better for clearing pityriasis versicolor, helping doctors choose the most effective option.
What could go wrong
This is a small, early-phase trial (Phase 1/2) with only 86 participants. Results may not apply to everyone, and both treatments have known side effects like skin irritation or stomach upset.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PITYRIASIS VERSICOLOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••